Genentech: Baris Bingol

I am proud to be part of the scientific team at Genentech that values scientific excellence above all to fuel therapeutic programs for patients in need.

Identification and characterization of a MAPT-targeting locked nucleic acid antisense oligonucleotide therapeutic for tauopathies: Molecular Therapy - Nucleic Acids

Genetic inactivation of RIP1 kinase activity in rats protects against ischemic brain injury. - Abstract - Europe PMC

Bay Area Molecular Neuroscience Meeting – July 20th, 2018 – UC Berkeley

Genentech: Eric Brown Vice President, Translational Biology

Swetha Chandrasekar on LinkedIn: Life update! This week, I moved out to the Bay Area and started a new…

Baris Bingol's Instagram, Twitter & Facebook on IDCrawl

PPEF2 Opposes PINK1-Mediated Mitochondrial Quality Control by Dephosphorylating Ubiquitin - ScienceDirect

Genentech: Domagoj Vucic Senior Fellow, Immunology Discovery

Genetic inactivation of RIP1 kinase activity in rats protects against ischemic brain injury

PTCD1 Is Required for Mitochondrial Oxidative-Phosphorylation: Possible Genetic Association with Alzheimer's Disease

Genentech: Brad Friedman Senior Principal Scientist, Bioinformatics & Computational Biology

Baris BINGOL, Genentech, California, Department of Neuroscience

Antibody News

Baris BINGOL, Genentech, California, Department of Neuroscience